Monopar again meets Nasdaq’s minimum bid price rule
Monopar Therapeutics Inc. WILMETTE, Ill., Aug. 27, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, today announced…
